Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Creese

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Life Sciences|January 11, 1992
Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatmentS X Xu, F J Monsma, D R Sibley, et al.
Life Sciences|June 25, 1979
Antischizophrenic drugs: differential plasma protein binding and therapeutic activityK A Freedberg, R B Innis, I Creese, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Dopamine receptor binding in the corpus striatum of mammalian brainD R Burt, S J Enna, I Creese, et al.
European Journal of Pharmacology|April 1, 1979
Opiate receptor binding affected differentially by opiates and opioid peptidesS R Childers, I Creese, A M Snowman, et al.
Life Sciences|November 18, 1985
Up-regulation of serotonergic binding sites labeled by [3H]WB4101 following fimbrial transection and 5,7-dihydroxytryptamine-induced lesionsA L Morrow, A B Norman, G Battaglia, et al.
Biological Psychiatry|July 1, 1982
High neuroleptic plasma levels in patients manifesting supersensitivity psychosisG Chouinard, I Creese, D Boisvert, et al.
European Journal of Pharmacology|February 11, 1986
Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatumE J Hess, G Battaglia, A B Norman, et al.
The American Journal of Psychiatry|January 1, 1980
Low neuroleptic serum levels in patients receiving fluphenazine decanoateL E Tune, I Creese, J T Coyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brainS X Xu, Y Hatada, L E Black, et al.
Nature|September 23, 1976
Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potencyS J Enna, J P Bennett, D R Burt, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Life Sciences|January 11, 1992
Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatmentS X Xu, F J Monsma, D R Sibley, et al.
Life Sciences|June 25, 1979
Antischizophrenic drugs: differential plasma protein binding and therapeutic activityK A Freedberg, R B Innis, I Creese, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Dopamine receptor binding in the corpus striatum of mammalian brainD R Burt, S J Enna, I Creese, et al.
European Journal of Pharmacology|April 1, 1979
Opiate receptor binding affected differentially by opiates and opioid peptidesS R Childers, I Creese, A M Snowman, et al.
Life Sciences|November 18, 1985
Up-regulation of serotonergic binding sites labeled by [3H]WB4101 following fimbrial transection and 5,7-dihydroxytryptamine-induced lesionsA L Morrow, A B Norman, G Battaglia, et al.
Biological Psychiatry|July 1, 1982
High neuroleptic plasma levels in patients manifesting supersensitivity psychosisG Chouinard, I Creese, D Boisvert, et al.
European Journal of Pharmacology|February 11, 1986
Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatumE J Hess, G Battaglia, A B Norman, et al.
The American Journal of Psychiatry|January 1, 1980
Low neuroleptic serum levels in patients receiving fluphenazine decanoateL E Tune, I Creese, J T Coyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brainS X Xu, Y Hatada, L E Black, et al.
Nature|September 23, 1976
Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potencyS J Enna, J P Bennett, D R Burt, et al.
Pageof 15